Arzeda, a University of Washington spinout that designs custom-built enzymes, is raising $12 million in Series A funding, according to Xconomy. OVP Venture Partners and WRF Capital have already signed onto the deal, which is expected to close in April.
Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!